The FDA stopped the production of all television and print ads for painkillers Celebrex and Bextra, stating did not emphasize the drugs' health risks to consumers. Both drugs are associated with an increased risk of heart attack. Drug company Pfizer spent $70 million on Celebrex advertisements in the U.S. last year. Few ads were launched for Bextra.
About the author: Mike Adams is a consumer health advocate with a mission to teach personal and planetary health to the public He has authored more than 1,800 articles and dozens of reports, guides and interviews on natural health topics, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is an independent journalist with strong ethics who does not get paid to write articles about any product or company. He has created over 100 CounterThink cartoons and produced several popular hip-hop songs on socially-conscious topics. He's also a noted pioneer in the email marketing software industry, having been the first to launch an HTML email newsletter technology that has grown to become a standard in the industry. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and practices nature photography, Capoeira, Pilates and organic gardening. Known by his callsign, the 'Health Ranger,' Adams posts his missions statements, health statistics and health photos at www.HealthRanger.org
Email this article to a friend 
Printable Version 
Wednesday, February 02, 2005
Email this article to a friend
Share this article on: 
